About Us
Shaping the future of autoimmune testing.
We’re a global market leader in autoimmune diagnostics, delivering highly accurate reagents and highly efficient automation to labs throughout the world.
News
Event
Closing the seronegative gap in Autoimmune testing
-
August 1, 2018 - August 1, 2018
3:45PM-5:30PM
Marriot Marquis Chicago - Great Lakes Ballroom E (Level 2)
2121 S Prairie AveChicago, CA 92131, United States
Schedule
6:45 AM Breakfast service starts
7:00 AM Presentations start
New markers hold great potential to improve care of Autoimmune diseases. We will discuss the advent of new markers for Connective Tissue Disease, Rheumatoid Arthritis, Antiphospholipid Syndrome, Myositis and Autoimmune Liver Disease which help close the seronegative gap. We will present an advanced technology for multi-analyte testing in Autoimmunity.
Registered attendees are eligible for CEU credit.
Not attending AACC? You can still register and view the recorded session to receive CEU credit.
Breakfast service will start at 6:45 AM
Multi-analyte detection of autoantibodies improves clinical assessment
Multi-analyte detection of autoantibodies improves clinical assessment
Carlos A. von Mühlen MD, PhD
Dr. von Mühlen has a Medical and Master’s degree in Clinical Medicine from Universidade Federal do Rio Grande do Sul, Brazil, and earned his PhD at the Rheinisch-Westfalische Technische Hochschule/Aachen School of Medicine, Germany. He also served as a Post-Doctoral Fellow in Autoimmune Diseases at the Scripps Research Institute under Eng M. Tan, MD.
Changing the paradigm in autoimmune myositis testing and impact on the autoimmune laboratory
Changing the paradigm in autoimmune myositis testing and impact on the autoimmune laboratory
Marvin Fritzler, MD, PhD
Dr. Fritzler is a Professor of Medicine at the University of Calgary with research interest in clinical immunology. He directs autoantibody testing at the Mitogen Advanced Diagnostics Laboratory.
Introduction of a novel particle-based multi-analyte test (PMAT) system as an aid in the diagnosis of autoimmune diseases
Introduction of a novel particle-based multi-analyte test (PMAT) system as an aid in the diagnosis of autoimmune diseases
Michael Mahler, PhD
Dr. Mahler is Vice President of Research and Development at Inova Diagnostics. His research is focused on discovery of novel autoantigens. He and his team identify and characterize autoimmune diagnostic assays and develop instrument systems.
Contact us
Please contact us directly via email, telephone, or with the following form.
EMAIL:
support@inovadx.com
TOLL FREE PHONE:
800.545.9495
PHONE:
858.586.9900
FAX:
858.586.9911
